Lin Ting-Yu, Chang Po-Jui, Lo Chun-Yu, Lo Yu-Lun, Yu Chih-Teng, Lin Shu-Min, Kuo Chih-His Scott, Lin Horng-Chyuan
Department of Thoracic Medicine, Chang Gung Memorial Hospital, Taipei, Taiwan.
College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Front Med (Lausanne). 2022 Apr 25;9:823994. doi: 10.3389/fmed.2022.823994. eCollection 2022.
The circulating progenitor cells of fibroblasts (fibrocytes) have been shown to infiltrate the airway smooth muscle compartment of asthma patients; however, the pathological significance of this discovery has yet to be elucidated. This study established a co-culture model of airway smooth muscle cells (ASMCs) and fibrocytes from asthmatic or normal subjects to evaluate innate cytokine production, corticosteroid responses, and signaling in ASMCs.
CD34 fibrocytes were purified from peripheral blood of asthmatic (Global Initiative for Asthma treatment step 4-5) and normal subjects and cultured for 5∼7 days. In a transwell plate, ASMCs were co-cultured with fibrocytes at a ratio of 2:1, ASMCs were cultured alone (control condition), and fibrocytes were cultured alone for 48 h. Measurements were obtained of interleukin-8 (IL-8), IL-6, IL-17, thymic stromal lymphopoietin, and IL-33 levels in the supernatant and IL-33 levels in the cell lysate of the co-culture. Screening for intracellular signaling in the ASMCs after stimulation was performed using condition medium from the patients' co-culture (PtCM) or IL-8. mRNA and western blot analysis were used to analyze AKT/mTOR signaling in ASMCs stimulated via treatment with PtCM or IL-8.
Compared with ASMCs cultured alone, IL-8 levels in the supernatant and IL-33 levels in the ASMCs lysate were significantly higher in samples co-cultured from asthmatics, but not in those co-cultured from normal subjects. Corticosteroid-induced suppression of IL-8 production was less pronounced in ASMCs co-cultured with fibrocytes from asthma patients than in ASMCs co-cultured from normal subjects. ASMCs stimulated using PtCM and IL-8 presented elevating activated AKT substrate PRAS40. Treatment with IL-8 and PtCM increased mRNA expression of mTOR and P70S6 kinases in ASMCs. Treatment with IL-8 and PtCM also significantly increased phosphorylation of AKT and mTOR subtract S6 ribosomal protein in ASMCs.
The interaction between ASMCs and fibrocytes from asthmatic patients was shown to increase IL-8 and IL-33 production and promote AKT/mTOR signaling in ASMCs. IL-8 production in the co-culture from asthmatic patients was less affected by corticosteroid than was that in the co-culture from normal subjects. Our results elucidate the novel role of fibrocytes and ASMCs in the pathogenesis of asthma.
成纤维细胞循环祖细胞(纤维细胞)已被证明可浸润哮喘患者的气道平滑肌区室;然而,这一发现的病理意义尚未阐明。本研究建立了哮喘患者或正常受试者的气道平滑肌细胞(ASMC)与纤维细胞的共培养模型,以评估ASMC中固有细胞因子的产生、皮质类固醇反应和信号传导。
从哮喘患者(全球哮喘防治创议治疗第4 - 5步)和正常受试者的外周血中纯化CD34纤维细胞,并培养5至7天。在Transwell板中,ASMC与纤维细胞以2:1的比例共培养,ASMC单独培养(对照条件),纤维细胞单独培养48小时。测量共培养上清液中白细胞介素-8(IL - 8)、IL - 6、IL - 17、胸腺基质淋巴细胞生成素和IL - 33水平以及共培养细胞裂解物中的IL - 33水平。使用患者共培养条件培养基(PtCM)或IL - 8对刺激后的ASMC进行细胞内信号筛选。采用mRNA和蛋白质印迹分析来分析经PtCM或IL - 8处理刺激的ASMC中的AKT/mTOR信号传导。
与单独培养的ASMC相比,哮喘患者共培养样本的上清液中IL - 8水平和ASMC裂解物中的IL - 33水平显著更高,但正常受试者共培养样本中则不然。与来自正常受试者共培养的ASMC相比,与哮喘患者纤维细胞共培养的ASMC中皮质类固醇诱导的IL - 8产生抑制作用不那么明显。使用PtCM和IL - 8刺激的ASMC呈现出活化的AKT底物PRAS40升高。用IL - 8和PtCM处理增加了ASMC中mTOR和P70S6激酶的mRNA表达。用IL - 8和PtCM处理也显著增加了ASMC中AKT和mTOR底物S6核糖体蛋白的磷酸化。
哮喘患者的ASMC与纤维细胞之间的相互作用显示可增加IL - 8和IL - 33的产生,并促进ASMC中的AKT/mTOR信号传导。哮喘患者共培养中的IL - 8产生受皮质类固醇的影响小于正常受试者共培养中的情况。我们的结果阐明了纤维细胞和ASMC在哮喘发病机制中的新作用。